Innovative Industrial Properties, Inc. (NYSE: IIPR) ("IIP" or the "Company") announced today results for the third quarter ended September 30, 2026.
Executive Chairman Remarks
“We are pleased to report strong earnings with our AFFO per share up 7% compared to the second quarter, and are encouraged by the continued leasing momentum across our portfolio, reflecting our team's ongoing efforts to re-lease properties,” said Alan Gold, Executive Chairman of IIP. “At the same time, our recently announced $245 million mezzanine loan commitment at Alewife Park further expands our presence in the life science sector. Together, these initiatives reflect our focus on improving the performance of our existing portfolio while deploying capital into investments that we believe will drive earnings growth and create long-term value for our shareholders.”
Third Quarter 2026
Financial Results and Dividend
|
| Three Months Ended | Three Months Ended | ||||||||||
|
| September 30, 2026 | September 30, 2025 | ||||||||||
|
| Amount | Per Share | Amount | Per Share | ||||||||
| Net income attributable to common stockholders | 28,708 | 0.99 | 28,288 | 0.97 | ||||||||
| Normalized FFO |
| 50,234 |
| 1.80 |
| 45,156 |
| 1.60 | ||||
| AFFO |
| 54,777 |
| 1.96 |
| 48,348 |
| 1.71 | ||||
| __________________________________________________________________ |
| Amounts in thousands, except per share amounts. Definitions of the above-mentioned non-GAAP financial measures, together with reconciliations to net income in accordance with GAAP and other definitions of capitalized terms used herein, appear at the end of this release. |
Life Science Investments
Portfolio - Leasing and Dispositions
Portfolio - Select Tenant Updates
| Three Months Ended | Three Months Ended | |||||||||||||||||||||||
| June 30, 2026 | September 30, 2026 | |||||||||||||||||||||||
| Tenant | Payments | Security Deposit Applied | Total | Per Share(1) | Payments | Security Deposit Applied | Total | Per Share(1) | ||||||||||||||||
| PharmaCann | 1.2 | — | 1.2 | 0.04 | 0.4 | — | 0.4 | 0.01 | ||||||||||||||||
| 4Front |
| 0.7 |
| — |
| 0.7 |
| 0.02 |
| 2.0 |
| — |
| 2.0 |
| 0.07 | ||||||||
| Parallel |
| 4.4 |
| — |
| 4.4 |
| 0.15 |
| — |
| 2.8 |
| 2.8 |
| 0.10 | ||||||||
| The Cannabist Company |
| 2.5 |
| 0.8 |
| 3.3 |
| 0.11 |
| 1.9 |
| 1.0 |
| 2.9 |
| 0.10 | ||||||||
| Battle Green |
| 0.3 |
| 0.6 |
| 0.9 |
| 0.03 |
| 3.5 |
| — |
| 3.5 |
| 0.13 | ||||||||
| Total | 9.1 | 1.4 | 10.5 | 0.35 | 7.8 | 3.8 | 11.6 | 0.41 | ||||||||||||||||
| ___________________________________________________________________ | ||
| (1) | For the three months ended June 30, 2026, the weighted-average diluted shares outstanding for FFO, Normalized FFO and AFFO was 28,972,371 shares. For the three months ended September 30, 2026, the weighted-average diluted shares outstanding for FFO, Normalized FFO and AFFO was 27,961,629 shares. | |
Balance Sheet Highlights (at September 30, 2026)
Financing Activity
Financial Results
For the three months ended September 30, 2026, IIP generated total revenues of $64.9 million, compared to $64.7 million for the same period in 2025, an increase of 0.4%. The increase was driven by higher revenue related to properties repossessed during the third quarter of 2026 as a result of the application of security deposits, partially offset by lower rental revenue from property sales and lease terminations after the third quarter of 2025.
For the three months ended September 30, 2026, the Company applied $3.8 million of security deposits on properties leased to The Cannabist and Parallel. During the three months ended September 30, 2025, the Company applied $0.8 million of security deposits on two properties leased to Verdant and a Sacramento tenant.
For the three months ended September 30, 2026, interest and other income increased by $9.9 million to $14.3 million compared to $4.4 million for the three months ended September 30, 2025. The increase was primarily driven by the recognition of $10.4 million of interest and dividend income related to our financial investments in IQHQ, as well as interest income recognized on the seller-financed note associated with the sale of a property in Perth, New York.
Dividend
On September 15, 2026, the Board of Directors declared a third quarter 2026 dividend of $1.90 per common share, representing an annualized dividend of $7.60 per common share. The dividend was paid on October 15, 2026 to stockholders of record as of September 30, 2026.
Supplemental Information
Supplemental financial information is available in the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com.
Teleconference and Webcast
The Company will conduct a conference call and webcast at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) on Tuesday, November 3, 2026 to discuss IIP’s financial results and operations for the third quarter ended September 30, 2026. The call will be open to all interested investors through a live audio webcast at the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com, or live by calling 1-833-461-5787 (domestic) or 1-585-542-9983 (international) and asking to be joined to the Innovative Industrial Properties, Inc. conference call using meeting ID 339722854. The complete webcast will be archived for one year on IIP’s website. The website replay will be posted in the Investor Relations section of innovativeindustrialproperties.com.
About Innovative Industrial Properties
Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties and life science real estate. Additional information is available at www.innovativeindustrialproperties.com.
This press release contains statements that IIP believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP “expects,” “intends,” “plans,” “estimates,” “anticipates,” “believes” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding potential transactions, including proposed leases of our properties, the consummation and timing of which remain subject to the negotiation and execution of definitive documentation, satisfaction of customary closing conditions and other contingencies, including those related to receivership sale processes; the anticipated timing, outcome and effects of pending receivership proceedings, including the effectiveness of arrangements with prospective new tenants for certain properties following the conclusion of such proceedings; and the expected transfer of existing cannabis licenses for certain properties to new tenants. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. You should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control and which could materially affect actual results, performances or achievements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the risk factors discussed in the Company's most recent Annual Report on Form 10-K for the year ended December 31, 2025, as updated by the Company’s subsequent reports filed with the Securities and Exchange Commission. Accordingly, there is no assurance that the Company's expectations will be realized. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by federal securities laws.
| INNOVATIVE INDUSTRIAL PROPERTIES, INC. | ||||||||
| CONSOLIDATED BALANCE SHEETS | ||||||||
| (Unaudited) | ||||||||
| (In thousands, except share and per share amounts) | ||||||||
|
| September 30, | December 31, | ||||||
| Assets | 2026 | 2025 | ||||||
| Real estate, at cost |
|
| ||||||
| Land | 141,289 |
| 146,320 |
| ||||
| Buildings and improvements |
| 2,191,688 |
|
| 2,269,597 |
| ||
| Construction in progress |
| 35,041 |
|
| 40,593 |
| ||
| Total real estate, at cost |
| 2,368,018 |
|
| 2,456,510 |
| ||
| Less accumulated depreciation |
| (387,234 |
| (343,062 | ||||
| Net real estate held for investment |
| 1,980,784 |
|
| 2,113,448 |
| ||
| Life science investments |
| 417,416 |
|
| 152,665 |
| ||
| Loans receivable |
| 71,800 |
|
| 22,800 |
| ||
| Cash and cash equivalents |
| 142,352 |
|
| 47,597 |
| ||
| Restricted cash |
| 2,908 |
|
| — |
| ||
| In-place lease intangible assets, net |
| 3,727 |
|
| 6,366 |
| ||
| Other assets, net |
| 31,728 |
|
| 27,982 |
| ||
| Total assets | 2,650,715 |
| 2,370,858 |
| ||||
|
|
|
| ||||||
| Liabilities and stockholders’ equity |
|
| ||||||
| Liabilities |
|
| ||||||
| Notes due 2026, net | — |
| 290,602 |
| ||||
| Exchangeable notes, net |
| 389,749 |
|
| — |
| ||
| Term loans, net |
| 118,710 |
|
| — |
| ||
| Revolving credit facilities |
| 187,500 |
|
| 102,500 |
| ||
| Accounts payable and accrued expenses |
| 13,358 |
|
| 10,870 |
| ||
| Dividends payable |
| 56,314 |
|
| 54,913 |
| ||
| Rent received in advance and tenant security deposits |
| 41,525 |
|
| 50,307 |
| ||
| Other liabilities |
| 13,077 |
|
| 13,662 |
| ||
| Total liabilities |
| 820,233 |
|
| 522,854 |
| ||
| Commitments and contingencies |
|
| ||||||
| Stockholders’ equity |
|
| ||||||
| Preferred stock, par value $0.001 per share, 75,000,000 shares authorized: 9.00% Series A cumulative redeemable preferred stock, liquidation preference of $25.00 per share, 5,666,082 and 2,019,525 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively |
| 128,995 |
|
| 47,780 |
| ||
| Common stock, par value $0.001 per share, 100,000,000 shares authorized: 27,570,861 and 28,022,975 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively |
| 28 |
|
| 28 |
| ||
| Additional paid-in capital |
| 2,075,619 |
|
| 2,113,184 |
| ||
| Dividends in excess of earnings |
| (374,160 |
| (312,988 | ||||
| Total stockholders’ equity |
| 1,830,482 |
|
| 1,848,004 |
| ||
| Total liabilities and stockholders’ equity | 2,650,715 |
| 2,370,858 |
| ||||
| INNOVATIVE INDUSTRIAL PROPERTIES, INC. | ||||||||||||||||
| CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||
|
| For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
| September 30, | September 30, | |||||||||||||||
|
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues |
|
|
|
| ||||||||||||
| Rental (including tenant reimbursements) | 64,743 |
| 64,292 |
| 196,553 |
| 198,855 |
| ||||||||
| Other |
| 177 |
|
| 393 |
|
| 678 |
|
| 443 |
| ||||
| Total revenues |
| 64,920 |
|
| 64,685 |
|
| 197,231 |
|
| 199,298 |
| ||||
|
|
|
|
|
| ||||||||||||
| Expenses |
|
|
|
| ||||||||||||
| Property expenses |
| 6,939 |
|
| 7,951 |
|
| 21,711 |
|
| 22,197 |
| ||||
| General and administrative expense |
| 8,458 |
|
| 8,681 |
|
| 26,526 |
|
| 25,768 |
| ||||
| Depreciation and amortization expense |
| 19,572 |
|
| 18,639 |
|
| 56,955 |
|
| 55,530 |
| ||||
| Impairment loss on real estate |
| 567 |
|
| — |
|
| 567 |
|
| 3,527 |
| ||||
| Total expenses |
| 35,536 |
|
| 35,271 |
|
| 105,759 |
|
| 107,022 |
| ||||
| Gain (loss) on sale of real estate, net |
| — |
|
| — |
|
| 12,269 |
|
| — |
| ||||
| Income from operations |
| 29,384 |
|
| 29,414 |
|
| 103,741 |
|
| 92,276 |
| ||||
| Interest and other income |
| 14,331 |
|
| 4,416 |
|
| 31,414 |
|
| 7,599 |
| ||||
| Interest expense |
| (11,820 |
| (4,525 |
| (26,599 |
| (13,469 | ||||||||
| Net income |
| 31,895 |
|
| 29,305 |
|
| 108,556 |
|
| 86,406 |
| ||||
| Preferred stock dividends |
| (3,187 |
| (1,017 |
| (9,028 |
| (2,676 | ||||||||
| Net income attributable to common stockholders | 28,708 |
| 28,288 |
| 99,528 |
| 83,730 |
| ||||||||
| Net income attributable to common stockholders per share |
|
|
|
| ||||||||||||
| Basic | 1.01 |
| 0.99 |
| 3.45 |
| 2.91 |
| ||||||||
| Diluted | 0.99 |
| 0.97 |
| 3.38 |
| 2.87 |
| ||||||||
| Weighted-average shares outstanding |
|
|
|
| ||||||||||||
| Basic |
| 27,356,738 |
|
| 27,912,881 |
|
| 27,928,270 |
|
| 28,036,179 |
| ||||
| Diluted |
| 27,961,629 |
|
| 28,303,600 |
|
| 28,465,209 |
|
| 28,402,063 |
| ||||
| INNOVATIVE INDUSTRIAL PROPERTIES, INC. | ||||||||||||||||
| FFO, NORMALIZED FFO AND AFFO | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||
|
| For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
| September 30, | September 30, | |||||||||||||||
|
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net income attributable to common stockholders | 28,708 |
| 28,288 |
| 99,528 |
| 83,730 |
| ||||||||
| Real estate depreciation and amortization |
| 19,572 |
|
| 18,639 |
|
| 56,955 |
|
| 55,530 |
| ||||
| Impairment loss on real estate |
| 567 |
|
| — |
|
| 567 |
|
| 3,527 |
| ||||
| Loss (gain) on sale of real estate, net |
| — |
|
| — |
|
| (12,269 |
| — |
| |||||
| FFO attributable to common stockholders |
| 48,847 |
|
| 46,927 |
|
| 144,781 |
|
| 142,787 |
| ||||
| Litigation-related expense |
| 784 |
|
| 604 |
|
| 3,966 |
|
| 1,423 |
| ||||
| Loss (gain) on partial repayment of notes due 2026 |
| — |
|
| — |
|
| — |
|
| (32 | |||||
| Income on seller-financed notes(1) |
| 223 |
|
| (2,375 |
| 669 |
|
| (1,058 | ||||||
| Deferred lease payments received on sales-type leases(2) |
| 351 |
|
| — |
|
| 1,051 |
|
| 25 |
| ||||
| Transaction costs and other(3) |
| 29 |
|
| — |
|
| (434 |
| — |
| |||||
| Normalized FFO attributable to common stockholders |
| 50,234 |
|
| 45,156 |
|
| 150,033 |
|
| 143,145 |
| ||||
| Stock-based compensation |
| 3,311 |
|
| 2,684 |
|
| 8,721 |
|
| 7,434 |
| ||||
| Non-cash interest expense |
| 1,545 |
|
| 485 |
|
| 3,402 |
|
| 1,431 |
| ||||
| Non-cash accretion of life science investments |
| (336 |
| — |
|
| (1,005 |
| — |
| ||||||
| Above-market lease amortization |
| 23 |
|
| 23 |
|
| 69 |
|
| 69 |
| ||||
| AFFO attributable to common stockholders | 54,777 |
| 48,348 |
| 161,220 |
| 152,079 |
| ||||||||
| FFO per common share – diluted | 1.75 |
| 1.66 |
| 5.09 |
| 5.03 |
| ||||||||
| Normalized FFO per common share – diluted | 1.80 |
| 1.60 |
| 5.27 |
| 5.04 |
| ||||||||
| AFFO per common share – diluted | 1.96 |
| 1.71 |
| 5.66 |
| 5.35 |
| ||||||||
| Weighted average common shares used for FFO, Normalized FFO, and AFFO: |
|
|
|
| ||||||||||||
| Basic |
| 27,356,738 |
|
| 27,912,881 |
|
| 27,928,270 |
|
| 28,036,179 |
| ||||
| Restricted stock and RSUs |
| 604,891 |
|
| 390,719 |
|
| 536,939 |
|
| 365,884 |
| ||||
| Diluted |
| 27,961,629 |
|
| 28,303,600 |
|
| 28,465,209 |
|
| 28,402,063 |
| ||||
| ____________________________________________________________________ | ||
| (1) | Positive amounts reflect non-refundable cash payments received pursuant to seller-financed notes issued by us in connection with our disposition of certain properties. As the transactions did not qualify for recognition as completed sales under GAAP, the payments are recorded as a deposit liability and included in other liabilities on our consolidated balance sheet. For both the three and nine months ended September 30, 2025, the negative amounts resulted from the recognition of $2.6 million of non-refundable cash payments received on one of the seller-financed notes as interest and other income in connection with the termination of the seller-financed note. | |
| (2) | Amounts reflect the non-refundable lease payments received on two sales-type leases which are recognized as a deposit liability and is included in other liabilities in our consolidated balance sheets as the transaction did not qualify for recognition as a completed sale. | |
| (3) | Amounts reflect other items that are considered to be infrequent and unusual in nature and/or not related to our core operations. For the nine months ended September 30, 2026, amount reflects certain financing costs that were not capitalizable and write-off of certain liabilities. | |
Non-GAAP Financial Measures
Funds From Operations (FFO)
FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (NAREIT). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income, computed in accordance with accounting principles generally accepted in the United States (GAAP), excluding gains (or losses) from sales of property, depreciation, amortization and impairment related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures.
Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of IIP's properties without giving effect to certain significant non-cash items, primarily depreciation expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. IIP believes that by excluding the effect of depreciation, FFO and FFO per share can facilitate comparisons of operating performance between periods. IIP reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share.
Normalized Funds from Operations (Normalized FFO)
IIP computes Normalized FFO by adjusting FFO, as defined by NAREIT, to exclude certain GAAP income and expense amounts that management believes are infrequent and unusual in nature and/or not related to IIP's core operations, as detailed in the reconciliation above. Exclusion of these items from similar FFO-type metrics is common within the equity REIT industry, and management believes that presentation of Normalized FFO and Normalized FFO per share provides investors with a metric to assist in their evaluation of IIP's operating performance across multiple periods and in comparison to the operating performance of other companies, because it removes the effect of unusual items that are not expected to impact IIP's operating performance on an ongoing basis. Normalized FFO is used by management in evaluating the performance of IIP's core business operations.
Adjusted Funds from Operations (AFFO)
Management believes that AFFO and AFFO per share are also appropriate supplemental measures of a REIT’s operating performance. IIP calculates AFFO by adjusting Normalized FFO for certain non-cash items, as detailed in the reconciliation above.
For the purposes of calculating FFO, Normalized FFO and AFFO per diluted share, the dilutive impact of the Exchangeable Notes under the if-converted method are excluded as management believes the evaluation of operating performance based on actual diluted shares outstanding is more appropriate to facilitate consistent comparisons between reporting periods and reflects the actual shares that are entitled to common stock dividends each period. For the three and nine months ended September 30, 2026, the weighted-average potential shares necessary to settle the Exchangeable Notes under the if-converted method were 5,800,549 and 2,294,722, respectively, and the cash interest expense relating to the Exchangeable Notes were $6.0 million and $7.0 million, respectively.
IIP’s computation of FFO, Normalized FFO and AFFO may differ from the methodology for calculating FFO, Normalized FFO and AFFO utilized by other equity REITs and, accordingly, may not be comparable to such REITs. Further, FFO, Normalized FFO and AFFO do not represent cash flow available for management’s discretionary use. FFO, Normalized FFO and AFFO should not be considered as an alternative to net income (computed in accordance with GAAP) as an indicator of IIP’s financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of IIP’s liquidity, nor is it indicative of funds available to fund IIP’s cash needs, including IIP’s ability to pay dividends or make distributions. FFO, Normalized FFO and AFFO should be considered only as supplements to net income computed in accordance with GAAP as measures of IIP’s operations.
| INNOVATIVE INDUSTRIAL PROPERTIES, INC. | ||||
| Net Debt to Adjusted EBITDA | ||||
| (Unaudited) | ||||
| (In thousands) | ||||
|
| For the Three Months Ended | |||
| September 30, 2026 | ||||
| Net income | 31,895 |
| ||
| Adjustments for EBITDA |
| |||
| Interest expense |
| 11,820 |
| |
| Taxes (including corporate tax expense in G&A expense) |
| 1 |
| |
| Depreciation and amortization expense |
| 19,572 |
| |
| Above-market lease amortization |
| 23 |
| |
| Non-cash accretion of life science investments |
| (336 | ||
| Corp. asset depreciation (included in G&A expense) |
| 23 |
| |
| EBITDA | 62,998 |
| ||
|
|
| |||
| Adjustments for Adjusted EBITDA |
| |||
| Stock-based compensation | 3,311 |
| ||
| Impairment loss on real estate |
| 567 |
| |
| Income on seller-financed notes |
| 223 |
| |
| Deferred lease payments received on sales-type leases |
| 351 |
| |
| Transaction costs and other |
| 29 |
| |
| Adjusted EBITDA | 67,479 |
| ||
|
|
| |||
| Adjusted EBITDA annualized | 269,916 |
| ||
|
|
| |||
| Total Debt | 711,561 |
| ||
| Cash and cash equivalents |
| (142,352 | ||
| Net Debt | 569,209 |
| ||
|
|
| |||
| Net Debt/Adjusted EBITDA |
| 2.1x |
| |
Definitions
EBITDA and Adjusted EBITDA: EBITDA is defined as earnings (net income per income statement) before interest expense, income taxes, depreciation and amortization (including above-market lease amortization and corporate asset depreciation) and non-cash accretion of life science investments. Adjusted EBITDA is EBITDA adjusted for non-cash stock-based compensation, gain (loss) on sale of real estate, impairment loss on real estate, income on seller-financed notes, deferred lease payments received on sales-type leases, non-recurring transaction costs, and miscellaneous other non-cash expenses.
Management believes EBITDA and Adjusted EBITDA are meaningful supplemental measures of a REIT’s performance because they provide additional information regarding our operating performance without giving effect to certain financing decisions, tax considerations and significant non-cash items. Adjusted EBITDA further excludes certain items that management does not consider representative of IIP's ongoing operating performance or that may vary significantly between periods, and includes certain cash receipts not included in EBITDA. Management believes these measures facilitate comparisons of IIP's operating performance between periods and with other REITs. In addition, EBITDA and Adjusted EBITDA are widely followed by industry analysts, lenders, investors, rating agencies, and others as a means of evaluating the operating performance of a company prior to servicing debt obligations. When considered together with Net Debt, Adjusted EBITDA also provides supplemental information regarding IIP’s financial leverage. For these reasons, management has deemed it appropriate to disclose and discuss EBITDA and Adjusted EBITDA. We do not use Adjusted EBITDA as an alternative measure to net earnings computed under GAAP or as an alternative to cash from operating activities computed under GAAP or as an indicator of our ability to fund our cash needs.
Net Debt: Calculated as the sum of the outstanding principal balance of the Exchangeable Notes, term loans, and the Revolving Credit Facilities, less cash and cash equivalents, as presented on IIP's consolidated balance sheet as of September 30, 2026.
Gross Assets: Calculated as total assets plus accumulated depreciation, as presented on IIP's consolidated balance sheet as of September 30, 2026.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261102517015/en/
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.